Hypersensitivity reactions after diagnostic nonvascular administration of iodine-based contrast media and gadolinium-based contrast agents and the role of the drug allergy specialist

  • Aart J. van der Molen*
  • , Francisco Vega
  • , Annick A.J.M van de Ven
  • , Ilona A. Dekkers
  • , José J. Laguna
  • *Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    6 Citations (Scopus)
    120 Downloads (Pure)

    Abstract

    The risk of hypersensitivity reactions (HSR) following nonvascular administration of contrast media (CM) for diagnostic studies is very low, likely due to minimal absorption into the systemic circulation. Most published individual cases of HSR after nonvascular CM administration are immediate reactions caused by ionic high-osmolar CM, few by nonionic low-osmolar CM, and none by gadolinium-based contrast agents. Measures to prevent recurrent HSR following nonvascular administration are similar to those recommended to prevent HSR after intravascular CM administration. Premedication as preventive measure has been abandoned, while switching to an alternative CM, preferably based on the results of an allergological analysis, is increasingly advocated. In selected scenarios, preventive measures may be minimized.

    Original languageEnglish
    Article number111803
    Number of pages10
    JournalEuropean Journal of Radiology
    Volume181
    DOIs
    Publication statusPublished - Dec-2024

    Keywords

    • Contrast media/administration and dosage
    • Drug administration routes
    • Fluoroscopy
    • Hypersensitivity
    • Magnetic resonance imaging
    • Tomography
    • X-ray computed

    Fingerprint

    Dive into the research topics of 'Hypersensitivity reactions after diagnostic nonvascular administration of iodine-based contrast media and gadolinium-based contrast agents and the role of the drug allergy specialist'. Together they form a unique fingerprint.

    Cite this